Please login to the form below

Not currently logged in
Email:
Password:

corruption

This page shows the latest corruption news and features for those working in and with pharma, biotech and healthcare.

After Cohen payment scandal, Novartis unveils new ethics chief

After Cohen payment scandal, Novartis unveils new ethics chief

He has also been chair of the anti-corruption task force of the business and industry advisory committee at the Organisation for Economic Co-operation and Development (OECD).

Latest news

More from news
Approximately 10 fully matching, plus 85 partially matching documents found.

Latest Intelligence

  • Made in China Made in China

    One of the most serious concerns is bribery, corruption and fraud, well-known problems in the country in recent times. ... So how does AZ ensure it doesn’t get entangled in bribery or corruption in China?

  • Creating a successful global compliance programme Creating a successful global compliance programme

    For example, the FCPA allows for a facilitation exception, but many other anti-corruption laws, including the UKBA, do not. ... The UK Anti-Corruption Strategy 2017-2022 plan also calls for applying behavioural sciences to anti-corruption by better

  • Risky business for pharma Risky business for pharma

    to consider, including but not limited to bribery and corruption, money laundering, competition and antitrust, cybersecurity, data privacy and regulation and compliance. ... especially, but not only, in the US”and he added that “[f] or [GSK], like

  • Stress testing for the perfect compliance storm Stress testing for the perfect compliance storm

    Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery. ... industry. The business model of pharmaceutical and life science

  • Tracking comms trends: tackling reputational issues head on Tracking comms trends: tackling reputational issues head on

    Exploitation. Nightmare. Corruption. These are just three of the words that appear on the first page of results when you Google 'pharmaceutical companies' online.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    Other problems befalling Colombia’ s healthcare system include corruption among the EPS providers – 14 out of 22 EPS-C providers have been sanctioned for collusion and there are allegations of fraud, ... In a move to combat corruption, the EPS are

  • Is MINT the next BRIC?

    For example: governmental promotion of generics in Brazil, heavy pharmaceutical marketing restrictions in Russia, controversial patent legislation in India and the recent clampdown on industry corruption in China.

  • Ageing in China: The Implications for Healthcare

    A hint of this trend is suggested by the ongoing campaign to reduce unnecessary and profit-driven prescriptions, as well as the recent anti-corruption investigations against multinational pharmaceutical companies.

  • The heart of the matter - Part 5

    Rise of the CIA. The battle to curb corruption has seen the introduction of Corporate Integrity Agreements (CIA) in the US, requiring pharmaceutical companies to put in place a comprehensive compliance ... The increased pressure to bolster compliance

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics